Related Experiment Video
Updated: Aug 9, 2026
Intracranial Pharmacotherapy and Pain Assays in Rodents
Published on: April 9, 2019
Decreased morphine analgesia in rat overexpressing beta-arrestin 2 at periaqueductal gray
Baohong Jiang1, Yufeng Shi, Haohong Li
1Pharmacology Research Center and Department of Pharmacology, Shanghai Medical College, Fudan University, Shanghai 200032, China. baohong_jiang@fudan.edu.cn
Abstract:
Beta-arrestin 2 plays important physiological roles in regulating the function of the mu opioid receptor (muOR) in vivo. Periaqueductal gray (PAG) is a potential structure where morphine produces its antinociception, but it is unclear whether beta-arrestin 2 plays its regulatory effect on morphine at PAG. In the present study beta-arrestin 2 overexpression was induced by adenovirus at PAG of rats. Morphine was administrated in these rats through PAG microinjection and systemic administration. The antinociceptive effects of morphine were abolished in rats received microinjection of morphine at PAG and partially attenuated in rats received systemic administration of morphine. These findings support the notion that PAG is an important site where beta-arrestin 2 plays its regulatory effects on morphine analgesia.
Insights
Beta-arrestin 2 regulates morphine analgesia in the periaqueductal gray (PAG). Overexpressing beta-arrestin 2 in the PAG abolished morphine
Area of Science:
- Neuroscience
- Pharmacology
- Molecular Biology
Background:
- Beta-arrestin 2 is crucial for regulating mu-opioid receptor (muOR) function.
- The periaqueductal gray (PAG) is implicated in morphine's antinociceptive effects.
- The role of beta-arrestin 2 in morphine's action within the PAG remains unclear.
Purpose of the Study:
- To investigate the regulatory role of beta-arrestin 2 in morphine analgesia within the rat PAG.
- To determine if beta-arrestin 2 modulates morphine's effects when administered directly into the PAG or systemically.
Main Methods:
- Adenovirus-mediated overexpression of beta-arrestin 2 was induced in the rat PAG.
- Morphine was administered via microinjection into the PAG and through systemic administration.
- Antinociceptive effects of morphine were assessed in rats with altered beta-arrestin 2 levels in the PAG.
Main Results:
- Overexpression of beta-arrestin 2 in the PAG abolished the antinociceptive effects of microinjected morphine.
- Systemic administration of morphine showed partially attenuated antinociceptive effects in rats with induced beta-arrestin 2 overexpression in the PAG.
Conclusions:
- The periaqueductal gray (PAG) is a key site where beta-arrestin 2 exerts its regulatory influence on morphine analgesia.
- Beta-arrestin 2 plays a significant role in modulating the efficacy of morphine, particularly when acting within the PAG.
